Influence of Mild Therapeutic Hypothermia on Leukocyte Count
Overview
Mild therapeutic hypothermia is indicated in patients surviving out-of-hospital cardiac arrest due to ventricular fibrillation. Potential immunologic responses are unknown.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
Participating in This Clinical Trial
Inclusion Criteria
- Survivors of cardiac arrest due to VF – Age 18-90 Exclusion Criteria:
- Suspected / proven pregnancy – Immunodeficiency
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 90 Years
Investigator Details
- Lead Sponsor
- Charite University, Berlin, Germany
- Provider of Information About this Clinical Study
- Charite University Medicine, Charite University Medicine
- Overall Official(s)
- Joerg C Schefold, MD, Principal Investigator, Charite University, Berlin, Germany
- Christian Storm, MD, Principal Investigator, Charite University, Berlin, Germany
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.